A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
Novartis
Novartis
Xencor, Inc.
Medicenna Therapeutics, Inc.
Carisma Therapeutics Inc
Salubris Biotherapeutics Inc
Eli Lilly and Company
Xencor, Inc.